Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster. Learn more.
NCATS pre-clinical programs and resources focus on key obstacles and inefficiencies in the translational process, overcoming bottlenecks that slow the development of new treatments for patients.
Learn more about how to access NCATS programs and expertise.
Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster. Learn more.
Developing new approaches and technologies to identify and validate potential drug targets in a more efficient and predictable way.
Enhancing testing systems to assess the effects of chemical compounds on cellular, molecular or biochemical processes of interest.
Creating probes to investigate biological processes and optimizing them to become potential drug candidates.
Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.
NCATS strives to create and test innovative methods and technologies that will enhance the development, testing and implementation of new drugs, diagnostics and other interventions. By improving the process by which these interventions are developed, NCATS aims to make translational science more efficient, less expensive and less risky. In this way, NCATS complements the work of the private sector and other NIH Institutes and Centers.